tetradecanoylphorbol acetate has been researched along with Cutaneous T-Cell Lymphoma in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Benoit, BM; Dentchev, T; Didigu, CA; Klein, RS; Loren, AW; Nattkemper, LA; Rook, AH; Shin, DB; Singer, EM; Wysocka, M; Yosipovitch, G | 1 |
| Bueso-Ramos, C; Duvic, M; Estrov, Z; Lee, BN; Reuben, JM; Tang, CK | 1 |
| Odum, N; Raghunath, PN; Vonderheid, E; Wasik, MA; Zhang, Q | 1 |
3 other study(ies) available for tetradecanoylphorbol acetate and Cutaneous T-Cell Lymphoma
| Article | Year |
|---|---|
IL-31 is produced by the malignant T-cell population in cutaneous T-Cell lymphoma and correlates with CTCL pruritus.
Topics: Aged; Aged, 80 and over; Case-Control Studies; CD4-Positive T-Lymphocytes; Dipeptidyl Peptidase 4; Female; Gene Expression Regulation, Neoplastic; Humans; Interleukins; Leukocytes, Mononuclear; Lymphoma, T-Cell, Cutaneous; Male; Middle Aged; Pruritus; Real-Time Polymerase Chain Reaction; Retrospective Studies; RNA, Messenger; T-Lymphocytes; Tetradecanoylphorbol Acetate | 2013 |
Dysregulated synthesis of intracellular type 1 and type 2 cytokines by T cells of patients with cutaneous T-cell lymphoma.
Topics: Case-Control Studies; Cytokines; Humans; In Vitro Techniques; Interferon-gamma; Interleukin-2; Interleukin-4; Lymphocyte Activation; Lymphoma, T-Cell, Cutaneous; Mycosis Fungoides; Prognosis; Sezary Syndrome; Skin Neoplasms; T-Lymphocyte Subsets; T-Lymphocytes; Tetradecanoylphorbol Acetate | 1999 |
Lack of phosphotyrosine phosphatase SHP-1 expression in malignant T-cell lymphoma cells results from methylation of the SHP-1 promoter.
Topics: Azacitidine; Base Sequence; Decitabine; DNA Methylation; DNA Modification Methylases; Gene Expression; Humans; Intracellular Signaling Peptides and Proteins; Janus Kinase 3; Lymphoma; Lymphoma, T-Cell, Cutaneous; Phosphorylation; Promoter Regions, Genetic; Protein Tyrosine Phosphatase, Non-Receptor Type 11; Protein Tyrosine Phosphatase, Non-Receptor Type 6; Protein Tyrosine Phosphatases; Protein-Tyrosine Kinases; Skin Neoplasms; Tetradecanoylphorbol Acetate; Transcription, Genetic; Tumor Cells, Cultured | 2000 |